Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

LARKEN LABS

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 28

FDA approve DOXYCYCLINE HYCLATE

Comment Full text

ABBVIE

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 27

FDA approve CYCLOSPORINE

Comment Full text

ABBVIE

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 25

FDA approve CYCLOSPORINE

Comment Full text

CARNEGIE

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 18

FDA approve BALSALAZIDE DISODIUM

Comment Full text

MANKIND PHARMA

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 21

FDA approve BUMETANIDE

Comment Full text

QILU PHARM HAINAN

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 39

FDA approve MICAFUNGIN SODIUM

Comment Full text

TORRENT

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 22

FDA approve MONTELUKAST SODIUM

Comment Full text

DR REDDYS

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 22

FDA approve LEVOCETIRIZINE DIHYDROCHLORIDE

Comment Full text

TORRENT PHARMS LTD

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 25

FDA approve MONTELUKAST SODIUM

Comment Full text

HIKMA

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 24

FDA approve OXCARBAZEPINE

Comment Full text
  • Previous
  • 105
  • 106
  • 107
  • 108
  • 109
  • Next

Search

News categories

  • Technical Exchange News(9838)
  • Event(407)
  • SEC News(165315)
  • FDA Approval(9306)
  • Company Report(721)
  • Business News(110710)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin